C92.22
Billable
Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
C92.22 is billable and can be used for reimbursement purposes.
AI Search
Analyze diagnoses and doctors notes
Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
C92.22 is billable and can be used for reimbursement purposes.